nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—melanoma	0.512	1	CbGaD
Bezafibrate—CYP1A1—Dacarbazine—melanoma	0.0992	0.508	CbGbCtD
Bezafibrate—CYP3A4—Temozolomide—melanoma	0.0553	0.283	CbGbCtD
Bezafibrate—CYP3A4—Vemurafenib—melanoma	0.0303	0.155	CbGbCtD
Bezafibrate—CYP3A4—Docetaxel—melanoma	0.0104	0.0533	CbGbCtD
Bezafibrate—PPARG—dermis—melanoma	0.00889	0.125	CbGeAlD
Bezafibrate—PPARG—leg—melanoma	0.00587	0.0825	CbGeAlD
Bezafibrate—PPARG—hindlimb—melanoma	0.00524	0.0737	CbGeAlD
Bezafibrate—PPARA—blood vessel—melanoma	0.00455	0.064	CbGeAlD
Bezafibrate—PPARG—appendage—melanoma	0.0045	0.0632	CbGeAlD
Bezafibrate—PPARA—neck—melanoma	0.00326	0.0458	CbGeAlD
Bezafibrate—HMGCR—hair follicle—melanoma	0.00323	0.0454	CbGeAlD
Bezafibrate—PPARG—endothelium—melanoma	0.00271	0.0382	CbGeAlD
Bezafibrate—PPARG—blood vessel—melanoma	0.0025	0.0352	CbGeAlD
Bezafibrate—PPARA—eye—melanoma	0.00242	0.0341	CbGeAlD
Bezafibrate—PPARA—retina—melanoma	0.0024	0.0338	CbGeAlD
Bezafibrate—CYP1A1—skin epidermis—melanoma	0.00228	0.032	CbGeAlD
Bezafibrate—PPARD—mammalian vulva—melanoma	0.00226	0.0317	CbGeAlD
Bezafibrate—HMGCR—neck—melanoma	0.00217	0.0305	CbGeAlD
Bezafibrate—PPARA—skin of body—melanoma	0.00211	0.0296	CbGeAlD
Bezafibrate—Indomethacin—GLO1—melanoma	0.00195	0.34	CrCbGaD
Bezafibrate—Transaminases increased—Carmustine—melanoma	0.00184	0.0241	CcSEcCtD
Bezafibrate—PPARG—neck—melanoma	0.00179	0.0252	CbGeAlD
Bezafibrate—Photosensitivity—Vemurafenib—melanoma	0.00175	0.0229	CcSEcCtD
Bezafibrate—PPARD—head—melanoma	0.00161	0.0227	CbGeAlD
Bezafibrate—Cholestasis—Temozolomide—melanoma	0.00143	0.0186	CcSEcCtD
Bezafibrate—HMGCR—skin of body—melanoma	0.0014	0.0197	CbGeAlD
Bezafibrate—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00138	0.0181	CcSEcCtD
Bezafibrate—PPARA—head—melanoma	0.00138	0.0193	CbGeAlD
Bezafibrate—HMGCR—mammalian vulva—melanoma	0.00128	0.018	CbGeAlD
Bezafibrate—Photosensitivity reaction—Vemurafenib—melanoma	0.00121	0.0159	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00117	0.0154	CcSEcCtD
Bezafibrate—PPARG—skin of body—melanoma	0.00116	0.0163	CbGeAlD
Bezafibrate—PPARD—lymph node—melanoma	0.00113	0.0159	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Temozolomide—melanoma	0.00108	0.0142	CcSEcCtD
Bezafibrate—PPARG—mammalian vulva—melanoma	0.00106	0.0149	CbGeAlD
Bezafibrate—Erythema multiforme—Vemurafenib—melanoma	0.00101	0.0132	CcSEcCtD
Bezafibrate—PPARA—lymph node—melanoma	0.000963	0.0135	CbGeAlD
Bezafibrate—Alopecia—Vemurafenib—melanoma	0.00094	0.0123	CcSEcCtD
Bezafibrate—Erythema—Vemurafenib—melanoma	0.000926	0.0121	CcSEcCtD
Bezafibrate—HMGCR—head—melanoma	0.000915	0.0129	CbGeAlD
Bezafibrate—Balsalazide—PPARG—melanoma	0.000907	0.158	CrCbGaD
Bezafibrate—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000903	0.0118	CcSEcCtD
Bezafibrate—Vascular purpura—Temozolomide—melanoma	0.000878	0.0115	CcSEcCtD
Bezafibrate—Purpura—Temozolomide—melanoma	0.000815	0.0107	CcSEcCtD
Bezafibrate—Liver function test abnormal—Dactinomycin—melanoma	0.000802	0.0105	CcSEcCtD
Bezafibrate—Myalgia—Vemurafenib—melanoma	0.000788	0.0103	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000782	0.0102	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000782	0.0102	CcSEcCtD
Bezafibrate—Pancytopenia—Bleomycin—melanoma	0.000764	0.01	CcSEcCtD
Bezafibrate—PPARG—head—melanoma	0.000756	0.0106	CbGeAlD
Bezafibrate—Infection—Vemurafenib—melanoma	0.000751	0.00982	CcSEcCtD
Bezafibrate—Liver function test abnormal—Carmustine—melanoma	0.00075	0.00982	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Docetaxel—melanoma	0.00072	0.00942	CcSEcCtD
Bezafibrate—Muscular weakness—Carmustine—melanoma	0.000717	0.00938	CcSEcCtD
Bezafibrate—Pancytopenia—Dactinomycin—melanoma	0.000713	0.00933	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Bleomycin—melanoma	0.000707	0.00926	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000707	0.00925	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000707	0.00925	CcSEcCtD
Bezafibrate—CYP1A1—skin of body—melanoma	0.000705	0.00991	CbGeAlD
Bezafibrate—Myocardial infarction—Bleomycin—melanoma	0.000703	0.0092	CcSEcCtD
Bezafibrate—Muscular weakness—Temozolomide—melanoma	0.000693	0.00906	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Temozolomide—melanoma	0.000693	0.00906	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000688	0.009	CcSEcCtD
Bezafibrate—Pancytopenia—Carmustine—melanoma	0.000667	0.00873	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000664	0.00868	CcSEcCtD
Bezafibrate—Bronchitis—Temozolomide—melanoma	0.000653	0.00854	CcSEcCtD
Bezafibrate—Constipation—Vemurafenib—melanoma	0.000646	0.00845	CcSEcCtD
Bezafibrate—Pancytopenia—Temozolomide—melanoma	0.000645	0.00844	CcSEcCtD
Bezafibrate—CYP1A1—mammalian vulva—melanoma	0.000643	0.00904	CbGeAlD
Bezafibrate—HMGCR—lymph node—melanoma	0.000641	0.00901	CbGeAlD
Bezafibrate—Glyburide—SLC15A2—melanoma	0.000631	0.11	CrCbGaD
Bezafibrate—Erectile dysfunction—Temozolomide—melanoma	0.000625	0.00818	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Temozolomide—melanoma	0.00062	0.00811	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000601	0.00786	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0006	0.00785	CcSEcCtD
Bezafibrate—Pharyngitis—Dactinomycin—melanoma	0.000596	0.0078	CcSEcCtD
Bezafibrate—Indomethacin—CXCL8—melanoma	0.000579	0.101	CrCbGaD
Bezafibrate—Alopecia—Bleomycin—melanoma	0.000569	0.00745	CcSEcCtD
Bezafibrate—Erythema multiforme—Dactinomycin—melanoma	0.000568	0.00743	CcSEcCtD
Bezafibrate—Erythema—Bleomycin—melanoma	0.000561	0.00734	CcSEcCtD
Bezafibrate—Hypersensitivity—Vemurafenib—melanoma	0.000557	0.00728	CcSEcCtD
Bezafibrate—Pharyngitis—Temozolomide—melanoma	0.000539	0.00706	CcSEcCtD
Bezafibrate—Urinary tract disorder—Temozolomide—melanoma	0.000537	0.00702	CcSEcCtD
Bezafibrate—Pruritus—Vemurafenib—melanoma	0.000534	0.00699	CcSEcCtD
Bezafibrate—Urethral disorder—Temozolomide—melanoma	0.000533	0.00697	CcSEcCtD
Bezafibrate—Alopecia—Dactinomycin—melanoma	0.000531	0.00695	CcSEcCtD
Bezafibrate—PPARG—lymph node—melanoma	0.000529	0.00744	CbGeAlD
Bezafibrate—Erythema—Dactinomycin—melanoma	0.000523	0.00684	CcSEcCtD
Bezafibrate—Anaemia—Bleomycin—melanoma	0.000518	0.00678	CcSEcCtD
Bezafibrate—Diarrhoea—Vemurafenib—melanoma	0.000517	0.00676	CcSEcCtD
Bezafibrate—Migraine—Docetaxel—melanoma	0.000514	0.00673	CcSEcCtD
Bezafibrate—Erythema multiforme—Temozolomide—melanoma	0.000514	0.00672	CcSEcCtD
Bezafibrate—Dizziness—Vemurafenib—melanoma	0.0005	0.00654	CcSEcCtD
Bezafibrate—Alopecia—Carmustine—melanoma	0.000497	0.0065	CcSEcCtD
Bezafibrate—Erythema—Carmustine—melanoma	0.00049	0.0064	CcSEcCtD
Bezafibrate—Anaemia—Dactinomycin—melanoma	0.000483	0.00632	CcSEcCtD
Bezafibrate—Liver function test abnormal—Docetaxel—melanoma	0.000482	0.00631	CcSEcCtD
Bezafibrate—Alopecia—Temozolomide—melanoma	0.00048	0.00628	CcSEcCtD
Bezafibrate—Myalgia—Bleomycin—melanoma	0.000477	0.00625	CcSEcCtD
Bezafibrate—Rash—Vemurafenib—melanoma	0.000476	0.00623	CcSEcCtD
Bezafibrate—Dermatitis—Vemurafenib—melanoma	0.000476	0.00623	CcSEcCtD
Bezafibrate—Headache—Vemurafenib—melanoma	0.000473	0.00619	CcSEcCtD
Bezafibrate—Erythema—Temozolomide—melanoma	0.000473	0.00619	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00047	0.00615	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00047	0.00615	CcSEcCtD
Bezafibrate—Cramp muscle—Docetaxel—melanoma	0.00047	0.00615	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Docetaxel—melanoma	0.000461	0.00603	CcSEcCtD
Bezafibrate—CYP1A1—head—melanoma	0.00046	0.00647	CbGeAlD
Bezafibrate—Infection—Bleomycin—melanoma	0.000455	0.00595	CcSEcCtD
Bezafibrate—Anaemia—Carmustine—melanoma	0.000452	0.00592	CcSEcCtD
Bezafibrate—Nausea—Vemurafenib—melanoma	0.000449	0.00587	CcSEcCtD
Bezafibrate—Thrombocytopenia—Bleomycin—melanoma	0.000448	0.00586	CcSEcCtD
Bezafibrate—Myalgia—Dactinomycin—melanoma	0.000445	0.00583	CcSEcCtD
Bezafibrate—Anaemia—Temozolomide—melanoma	0.000437	0.00572	CcSEcCtD
Bezafibrate—Pancytopenia—Docetaxel—melanoma	0.000429	0.00561	CcSEcCtD
Bezafibrate—Infection—Dactinomycin—melanoma	0.000424	0.00555	CcSEcCtD
Bezafibrate—Thrombocytopenia—Dactinomycin—melanoma	0.000418	0.00547	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000417	0.00546	CcSEcCtD
Bezafibrate—Myalgia—Carmustine—melanoma	0.000417	0.00545	CcSEcCtD
Bezafibrate—Myalgia—Temozolomide—melanoma	0.000403	0.00527	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—melanoma	0.0004	0.0697	CrCbGaD
Bezafibrate—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000399	0.00522	CcSEcCtD
Bezafibrate—Infection—Carmustine—melanoma	0.000397	0.00519	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Docetaxel—melanoma	0.000397	0.00519	CcSEcCtD
Bezafibrate—Myocardial infarction—Docetaxel—melanoma	0.000395	0.00516	CcSEcCtD
Bezafibrate—Pain—Bleomycin—melanoma	0.000391	0.00512	CcSEcCtD
Bezafibrate—Thrombocytopenia—Carmustine—melanoma	0.000391	0.00512	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000389	0.00509	CcSEcCtD
Bezafibrate—Infection—Temozolomide—melanoma	0.000384	0.00502	CcSEcCtD
Bezafibrate—Balsalazide—PTGS2—melanoma	0.000383	0.0668	CrCbGaD
Bezafibrate—Thrombocytopenia—Temozolomide—melanoma	0.000378	0.00495	CcSEcCtD
Bezafibrate—Pain—Dactinomycin—melanoma	0.000365	0.00478	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Carmustine—melanoma	0.000364	0.00476	CcSEcCtD
Bezafibrate—Urticaria—Bleomycin—melanoma	0.000364	0.00476	CcSEcCtD
Bezafibrate—Insomnia—Carmustine—melanoma	0.000361	0.00473	CcSEcCtD
Bezafibrate—Pharyngitis—Docetaxel—melanoma	0.000359	0.00469	CcSEcCtD
Bezafibrate—Urinary tract disorder—Docetaxel—melanoma	0.000357	0.00467	CcSEcCtD
Bezafibrate—Urethral disorder—Docetaxel—melanoma	0.000354	0.00463	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000352	0.0046	CcSEcCtD
Bezafibrate—Insomnia—Temozolomide—melanoma	0.000349	0.00457	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dactinomycin—melanoma	0.000349	0.00457	CcSEcCtD
Bezafibrate—Erythema multiforme—Docetaxel—melanoma	0.000342	0.00447	CcSEcCtD
Bezafibrate—Pain—Carmustine—melanoma	0.000342	0.00447	CcSEcCtD
Bezafibrate—Constipation—Carmustine—melanoma	0.000342	0.00447	CcSEcCtD
Bezafibrate—Dyspepsia—Temozolomide—melanoma	0.00034	0.00445	CcSEcCtD
Bezafibrate—Abdominal pain—Dactinomycin—melanoma	0.000337	0.00441	CcSEcCtD
Bezafibrate—Hypersensitivity—Bleomycin—melanoma	0.000337	0.00441	CcSEcCtD
Bezafibrate—Pain—Temozolomide—melanoma	0.00033	0.00432	CcSEcCtD
Bezafibrate—Constipation—Temozolomide—melanoma	0.00033	0.00432	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Carmustine—melanoma	0.000327	0.00427	CcSEcCtD
Bezafibrate—Pruritus—Bleomycin—melanoma	0.000324	0.00424	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—melanoma	0.000322	0.00453	CbGeAlD
Bezafibrate—Alopecia—Docetaxel—melanoma	0.000319	0.00418	CcSEcCtD
Bezafibrate—Abdominal pain—Carmustine—melanoma	0.000316	0.00413	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Temozolomide—melanoma	0.000316	0.00413	CcSEcCtD
Bezafibrate—Erythema—Docetaxel—melanoma	0.000315	0.00412	CcSEcCtD
Bezafibrate—Hypersensitivity—Dactinomycin—melanoma	0.000315	0.00411	CcSEcCtD
Bezafibrate—Urticaria—Temozolomide—melanoma	0.000307	0.00401	CcSEcCtD
Bezafibrate—Abdominal pain—Temozolomide—melanoma	0.000305	0.00399	CcSEcCtD
Bezafibrate—Muscle spasms—Docetaxel—melanoma	0.000302	0.00396	CcSEcCtD
Bezafibrate—Hypersensitivity—Carmustine—melanoma	0.000294	0.00385	CcSEcCtD
Bezafibrate—Diarrhoea—Dactinomycin—melanoma	0.000292	0.00382	CcSEcCtD
Bezafibrate—Anaemia—Docetaxel—melanoma	0.000291	0.0038	CcSEcCtD
Bezafibrate—Rash—Bleomycin—melanoma	0.000289	0.00378	CcSEcCtD
Bezafibrate—Dermatitis—Bleomycin—melanoma	0.000288	0.00377	CcSEcCtD
Bezafibrate—Hypersensitivity—Temozolomide—melanoma	0.000284	0.00372	CcSEcCtD
Bezafibrate—Diarrhoea—Carmustine—melanoma	0.000273	0.00358	CcSEcCtD
Bezafibrate—Pruritus—Temozolomide—melanoma	0.000273	0.00357	CcSEcCtD
Bezafibrate—Nausea—Bleomycin—melanoma	0.000272	0.00356	CcSEcCtD
Bezafibrate—Rash—Dactinomycin—melanoma	0.000269	0.00352	CcSEcCtD
Bezafibrate—Myalgia—Docetaxel—melanoma	0.000268	0.0035	CcSEcCtD
Bezafibrate—Dizziness—Carmustine—melanoma	0.000264	0.00346	CcSEcCtD
Bezafibrate—Diarrhoea—Temozolomide—melanoma	0.000264	0.00346	CcSEcCtD
Bezafibrate—Dizziness—Temozolomide—melanoma	0.000255	0.00334	CcSEcCtD
Bezafibrate—Infection—Docetaxel—melanoma	0.000255	0.00334	CcSEcCtD
Bezafibrate—Nausea—Dactinomycin—melanoma	0.000254	0.00332	CcSEcCtD
Bezafibrate—Rash—Carmustine—melanoma	0.000252	0.0033	CcSEcCtD
Bezafibrate—Dermatitis—Carmustine—melanoma	0.000252	0.00329	CcSEcCtD
Bezafibrate—Thrombocytopenia—Docetaxel—melanoma	0.000251	0.00329	CcSEcCtD
Bezafibrate—Headache—Carmustine—melanoma	0.00025	0.00327	CcSEcCtD
Bezafibrate—Rash—Temozolomide—melanoma	0.000243	0.00318	CcSEcCtD
Bezafibrate—Dermatitis—Temozolomide—melanoma	0.000243	0.00318	CcSEcCtD
Bezafibrate—Headache—Temozolomide—melanoma	0.000242	0.00316	CcSEcCtD
Bezafibrate—Nausea—Carmustine—melanoma	0.000237	0.0031	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000234	0.00306	CcSEcCtD
Bezafibrate—Insomnia—Docetaxel—melanoma	0.000232	0.00304	CcSEcCtD
Bezafibrate—Nausea—Temozolomide—melanoma	0.000229	0.003	CcSEcCtD
Bezafibrate—Dyspepsia—Docetaxel—melanoma	0.000226	0.00296	CcSEcCtD
Bezafibrate—Pain—Docetaxel—melanoma	0.00022	0.00287	CcSEcCtD
Bezafibrate—Constipation—Docetaxel—melanoma	0.00022	0.00287	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Docetaxel—melanoma	0.00021	0.00275	CcSEcCtD
Bezafibrate—Abdominal pain—Docetaxel—melanoma	0.000203	0.00266	CcSEcCtD
Bezafibrate—Hypersensitivity—Docetaxel—melanoma	0.000189	0.00247	CcSEcCtD
Bezafibrate—Pruritus—Docetaxel—melanoma	0.000182	0.00238	CcSEcCtD
Bezafibrate—Diarrhoea—Docetaxel—melanoma	0.000176	0.0023	CcSEcCtD
Bezafibrate—Dizziness—Docetaxel—melanoma	0.00017	0.00222	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—melanoma	0.000169	0.0294	CrCbGaD
Bezafibrate—Rash—Docetaxel—melanoma	0.000162	0.00212	CcSEcCtD
Bezafibrate—Dermatitis—Docetaxel—melanoma	0.000162	0.00212	CcSEcCtD
Bezafibrate—Headache—Docetaxel—melanoma	0.000161	0.0021	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—melanoma	0.000156	0.0273	CrCbGaD
Bezafibrate—Nausea—Docetaxel—melanoma	0.000153	0.002	CcSEcCtD
Bezafibrate—Indomethacin—ALB—melanoma	0.00015	0.0262	CrCbGaD
Bezafibrate—Indomethacin—ABCB1—melanoma	0.000144	0.025	CrCbGaD
Bezafibrate—Glyburide—ALB—melanoma	0.000136	0.0237	CrCbGaD
Bezafibrate—Glyburide—ABCB1—melanoma	0.00013	0.0226	CrCbGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—FASN—melanoma	2.6e-05	0.000186	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.58e-05	0.000185	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP17A1—melanoma	2.54e-05	0.000182	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK3—melanoma	2.52e-05	0.00018	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.51e-05	0.000179	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC6A11—melanoma	2.49e-05	0.000179	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIP4K2A—melanoma	2.49e-05	0.000179	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—melanoma	2.48e-05	0.000177	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—melanoma	2.47e-05	0.000177	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PRKCA—melanoma	2.47e-05	0.000177	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—melanoma	2.46e-05	0.000176	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ERCC2—melanoma	2.45e-05	0.000176	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.44e-05	0.000175	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLCB4—melanoma	2.43e-05	0.000174	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTAP—melanoma	2.42e-05	0.000174	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GNA11—melanoma	2.4e-05	0.000172	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK1—melanoma	2.4e-05	0.000172	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—melanoma	2.4e-05	0.000172	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	2.39e-05	0.000171	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—VCAN—melanoma	2.37e-05	0.00017	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.37e-05	0.00017	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—FASN—melanoma	2.35e-05	0.000168	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH1—melanoma	2.33e-05	0.000167	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CG—melanoma	2.33e-05	0.000167	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CDKN2B—melanoma	2.32e-05	0.000166	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC5A5—melanoma	2.31e-05	0.000165	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC6A11—melanoma	2.29e-05	0.000164	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIP4K2A—melanoma	2.29e-05	0.000164	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—melanoma	2.28e-05	0.000163	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—melanoma	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PRKCA—melanoma	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—VDR—melanoma	2.26e-05	0.000162	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.24e-05	0.000161	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—melanoma	2.24e-05	0.000161	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ERCC2—melanoma	2.24e-05	0.000161	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GNAQ—melanoma	2.23e-05	0.00016	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CD44—melanoma	2.23e-05	0.00016	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTAP—melanoma	2.22e-05	0.000159	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—melanoma	2.2e-05	0.000157	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.18e-05	0.000156	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.17e-05	0.000156	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—melanoma	2.17e-05	0.000155	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.17e-05	0.000155	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.16e-05	0.000155	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PHGDH—melanoma	2.16e-05	0.000155	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LUM—melanoma	2.16e-05	0.000155	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1B1—melanoma	2.14e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—melanoma	2.13e-05	0.000152	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HPSE—melanoma	2.12e-05	0.000152	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NFKB1—melanoma	2.1e-05	0.000151	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PRKCA—melanoma	2.08e-05	0.000149	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CUBN—melanoma	2.08e-05	0.000149	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ERCC2—melanoma	2.07e-05	0.000148	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CD—melanoma	2.04e-05	0.000146	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.03e-05	0.000145	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACER3—melanoma	2.02e-05	0.000145	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—melanoma	2.02e-05	0.000145	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BSG—melanoma	2.01e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CSPG4—melanoma	2.01e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SDHD—melanoma	2.01e-05	0.000144	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP17A1—melanoma	2e-05	0.000143	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LUM—melanoma	1.98e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PHGDH—melanoma	1.98e-05	0.000142	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.97e-05	0.000141	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.95e-05	0.00014	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPAM—melanoma	1.95e-05	0.000139	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HPSE—melanoma	1.94e-05	0.000139	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—melanoma	1.94e-05	0.000139	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—melanoma	1.92e-05	0.000138	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—melanoma	1.91e-05	0.000137	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CUBN—melanoma	1.91e-05	0.000137	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—melanoma	1.89e-05	0.000135	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNA11—melanoma	1.89e-05	0.000135	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.89e-05	0.000135	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—melanoma	1.89e-05	0.000135	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—melanoma	1.87e-05	0.000134	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—melanoma	1.87e-05	0.000134	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.86e-05	0.000133	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	1.85e-05	0.000133	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UGT2B10—melanoma	1.85e-05	0.000133	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—FASN—melanoma	1.85e-05	0.000132	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SDHD—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BSG—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CSPG4—melanoma	1.84e-05	0.000132	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC5A5—melanoma	1.82e-05	0.00013	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—melanoma	1.81e-05	0.000129	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPAM—melanoma	1.78e-05	0.000128	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—melanoma	1.78e-05	0.000128	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—melanoma	1.77e-05	0.000127	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—melanoma	1.77e-05	0.000126	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—melanoma	1.76e-05	0.000126	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GNAQ—melanoma	1.76e-05	0.000126	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD44—melanoma	1.76e-05	0.000126	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HS3ST5—melanoma	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK1—melanoma	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—melanoma	1.72e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—melanoma	1.71e-05	0.000122	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.7e-05	0.000122	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—melanoma	1.7e-05	0.000122	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—melanoma	1.7e-05	0.000122	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—melanoma	1.69e-05	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1B1—melanoma	1.68e-05	0.000121	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—melanoma	1.68e-05	0.00012	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH1—melanoma	1.67e-05	0.00012	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLA2G6—melanoma	1.65e-05	0.000118	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—melanoma	1.65e-05	0.000118	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—melanoma	1.64e-05	0.000117	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—melanoma	1.62e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PRKCA—melanoma	1.62e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ERCC2—melanoma	1.61e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—melanoma	1.56e-05	0.000112	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLA2G6—melanoma	1.52e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—VCAN—melanoma	1.49e-05	0.000106	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.49e-05	0.000106	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—melanoma	1.48e-05	0.000106	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—melanoma	1.47e-05	0.000105	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.41e-05	0.000101	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—melanoma	1.39e-05	9.93e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—melanoma	1.38e-05	9.88e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—VCAN—melanoma	1.36e-05	9.76e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.36e-05	9.72e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—melanoma	1.36e-05	9.72e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—melanoma	1.34e-05	9.63e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.33e-05	9.54e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—melanoma	1.32e-05	9.45e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCB4—melanoma	1.3e-05	9.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.29e-05	9.24e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—melanoma	1.29e-05	9.23e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—melanoma	1.28e-05	9.18e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PRKCA—melanoma	1.28e-05	9.14e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—melanoma	1.27e-05	9.09e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ERCC2—melanoma	1.27e-05	9.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP17A1—melanoma	1.25e-05	8.98e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—melanoma	1.25e-05	8.98e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.24e-05	8.92e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.24e-05	8.86e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC6A11—melanoma	1.23e-05	8.78e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIP4K2A—melanoma	1.23e-05	8.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.22e-05	8.74e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—melanoma	1.22e-05	8.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTAP—melanoma	1.19e-05	8.55e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNA11—melanoma	1.18e-05	8.48e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—melanoma	1.17e-05	8.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FASN—melanoma	1.16e-05	8.3e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP17A1—melanoma	1.15e-05	8.23e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—melanoma	1.14e-05	8.17e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC5A5—melanoma	1.14e-05	8.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.13e-05	8.12e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.12e-05	8.02e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—melanoma	1.12e-05	7.99e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—melanoma	1.1e-05	7.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GNAQ—melanoma	1.1e-05	7.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD44—melanoma	1.1e-05	7.88e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—melanoma	1.09e-05	7.78e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNA11—melanoma	1.09e-05	7.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.08e-05	7.72e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.07e-05	7.65e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PHGDH—melanoma	1.06e-05	7.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LUM—melanoma	1.06e-05	7.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FASN—melanoma	1.06e-05	7.61e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP1B1—melanoma	1.06e-05	7.56e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.05e-05	7.51e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC5A5—melanoma	1.05e-05	7.48e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HPSE—melanoma	1.04e-05	7.47e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CUBN—melanoma	1.02e-05	7.33e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GNAQ—melanoma	1.01e-05	7.23e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD44—melanoma	1.01e-05	7.23e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—melanoma	1e-05	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BSG—melanoma	9.89e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CSPG4—melanoma	9.89e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SDHD—melanoma	9.89e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.88e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.79e-06	7.01e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—melanoma	9.73e-06	6.97e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1B1—melanoma	9.68e-06	6.93e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—melanoma	9.65e-06	6.91e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—melanoma	9.64e-06	6.9e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPAM—melanoma	9.58e-06	6.86e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.32e-06	6.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—melanoma	9.24e-06	6.61e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—melanoma	9.05e-06	6.48e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—melanoma	8.98e-06	6.43e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—melanoma	8.87e-06	6.35e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—melanoma	8.79e-06	6.29e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—melanoma	8.69e-06	6.23e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—melanoma	8.69e-06	6.22e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—melanoma	8.68e-06	6.21e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.54e-06	6.12e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—melanoma	8.41e-06	6.02e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—melanoma	8.27e-06	5.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G6—melanoma	8.14e-06	5.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PRKCA—melanoma	8e-06	5.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—melanoma	7.97e-06	5.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ERCC2—melanoma	7.93e-06	5.68e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—melanoma	7.66e-06	5.49e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—melanoma	7.59e-06	5.44e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—melanoma	7.39e-06	5.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PRKCA—melanoma	7.33e-06	5.25e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—VCAN—melanoma	7.31e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ERCC2—melanoma	7.27e-06	5.21e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—melanoma	6.76e-06	4.84e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—melanoma	6.62e-06	4.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.57e-06	4.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—melanoma	6.27e-06	4.49e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—melanoma	6.23e-06	4.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP17A1—melanoma	6.17e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—melanoma	6.05e-06	4.33e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.03e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—melanoma	5.93e-06	4.25e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNA11—melanoma	5.83e-06	4.17e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—melanoma	5.74e-06	4.11e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FASN—melanoma	5.7e-06	4.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A5—melanoma	5.61e-06	4.02e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—melanoma	5.54e-06	3.97e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—melanoma	5.51e-06	3.94e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—melanoma	5.44e-06	3.89e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GNAQ—melanoma	5.42e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD44—melanoma	5.42e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1B1—melanoma	5.19e-06	3.72e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—melanoma	5.05e-06	3.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—melanoma	4.99e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—melanoma	4.84e-06	3.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—melanoma	4.8e-06	3.44e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—melanoma	4.76e-06	3.41e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—melanoma	4.67e-06	3.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—melanoma	4.4e-06	3.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—melanoma	4.36e-06	3.12e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—melanoma	4.28e-06	3.06e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—melanoma	4.15e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PRKCA—melanoma	3.94e-06	2.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ERCC2—melanoma	3.9e-06	2.8e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—melanoma	3.81e-06	2.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—melanoma	3.8e-06	2.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—melanoma	3.08e-06	2.21e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—melanoma	2.98e-06	2.13e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—melanoma	2.93e-06	2.1e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—melanoma	2.71e-06	1.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—melanoma	2.68e-06	1.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—melanoma	2.68e-06	1.92e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—melanoma	2.39e-06	1.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—melanoma	2.36e-06	1.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—melanoma	2.34e-06	1.68e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—melanoma	2.19e-06	1.57e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—melanoma	2.04e-06	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—melanoma	1.44e-06	1.03e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—melanoma	1.18e-06	8.43e-06	CbGpPWpGaD
